美国州级堕胎限制与 COVID-19 大流行早期药物流产服务创新的关联。
The association of U.S. state-level abortion restrictions with medication abortion service delivery innovations during the early COVID-19 pandemic.
机构信息
Brigham and Women's Hospital, Boston, MA, United States; Harvard Medical School, Boston, MA, United States; Planned Parenthood League of Massachusetts, Boston, MA, United States.
Planned Parenthood League of Massachusetts, Boston, MA, United States; Heller School for Social Policy and Management, Brandeis University, Waltham, MA, United States.
出版信息
Contraception. 2022 Sep;113:26-29. doi: 10.1016/j.contraception.2022.04.003. Epub 2022 Apr 14.
OBJECTIVES
To assess whether state-level abortion restrictions resulted in differential uptake of innovative medication abortion practices such as changing ultrasound requirements, offering telehealth, or dispensing medications without a physical exam during the early COVID-19 pandemic.
METHODS
We used data from a prospective national survey of abortion providers to assess the association between a novel index of state-level abortion hostility and adoption of medication abortion services innovations during the pandemic.
RESULTS
Clinics in states with low or medium hostility were more likely to adopt innovative practices than those in high or extreme hostility states.
CONCLUSIONS
Clinics in abortion hostile states were less likely to adopt clinical recommendations and public health best practices for abortion care during the COVID-19 pandemic.
目的
评估州级堕胎限制是否导致创新性药物流产实践（如改变超声要求、提供远程医疗或在 COVID-19 大流行期间无需体检即可配药）的采用存在差异。
方法
我们使用一项针对堕胎提供者的前瞻性全国性调查的数据，评估了一种新型州级堕胎敌对指数与大流行期间药物流产服务创新采用之间的关联。
结果
与高敌对或极敌对州的诊所相比，敌对程度低或中等的州的诊所更有可能采用创新实践。
结论
在 COVID-19 大流行期间，堕胎敌对州的诊所不太可能采用堕胎护理的临床建议和公共卫生最佳实践。
Zotero 插件